Kai Tan

Kai Tan

Auto-generated profile, based on publicly available information

Kai Tan

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2022 in Nature
Verified
Journal Article
Closed access
PDF file
Jan Joseph MelenhorstJan Joseph Melenhorst
Jan Joseph Melenhorst
GCGregory M. Chen
Gregory M. Chen
MWMeng Wang
Meng Wang
DPDavid L. Porter
David L. Porter
CCChangya Chen
Changya Chen
CJCarl H. June
Carl H. June

1 March 2010 in Cell
Verified
Journal Article
Closed access
TRTimothy Ravasi
Timothy Ravasi
HSHarukazu Suzuki
Harukazu Suzuki
CCCarlo Vittorio Cannistraci
Carlo Vittorio Cannistraci
SKShintaro Katayama
Shintaro Katayama
VBVladimir Bajic
Vladimir Bajic
YHYoshihide Hayashizaki
Yoshihide Hayashizaki

20 September 2019 in Science
Verified
Journal Article
Closed access
PDF file
JPJonathan S. Packer
Jonathan S. Packer
QZQin Zhu
Qin Zhu
CHChau Huynh
Chau Huynh
PSPriya Sivaramakrishnan
Priya Sivaramakrishnan
EPElicia Preston
Elicia Preston
JMJohn I. Murray
John I. Murray
Identifying terminal nematode cells: Single-cell RNA sequencing provides the power to identify the developmental trajectory of an organism. However, identifying the temporal lineage of cell development can be difficult without large-scale analyses. Packer et al. sequenced more than 80,000 cells from embryos of the roundworm Caenorhabditis elegans to determine the expression of genes directing the development of terminal cell types. Because all somatic cells in a C. elegans individual have been mapped, the authors are able to connect gene expression with cell lineages over time during development, noting stark transitions in some cases. Science , this issue p. eaax1971

16 April 2020 in Cell
Verified
Journal Article
Open access
OROrit Rozenblatt-Rosen
Orit Rozenblatt-Rosen
ARAviv Regev
Aviv Regev
POPhilipp Oberdoerffer
Philipp Oberdoerffer
TNTal Nawy
Tal Nawy
AHAnna Hupalowska
Anna Hupalowska
XZXiaowei Zhuang
Xiaowei Zhuang
Crucial transitions in cancer-including tumor initiation, local expansion, metastasis, and therapeutic resistance-involve complex interactions between cells within the dynamic tumor ecosystem. Transformative single-cell genomics technologies and spatial multiplex in situ methods now provide an opportunity to interrogate this complexity at unprecedented resolution. The Human Tumor Atlas Network (HTAN), part of the National Cancer Institute (NCI) Cancer Moonshot Initiative, will establish a clinical, experimental, computational, and organizational framework to generate informative and accessible three-dimensional atlases of cancer transitions for a diverse set of tumor types. This effort complements both ongoing efforts to map healthy organs and previous large-scale cancer genomics approaches focused on bulk sequencing at a single point in time. Generating single-cell, multiparametric, longitudinal atlases and integrating them with clinical outcomes should help identify novel predictive biomarkers and features as well as therapeutically relevant cell types, cell states, and cellular interactions across transitions. The resulting tumor atlases should have a profound impact on our understanding of cancer biology and have the potential to improve cancer detection, prevention, and therapeutic discovery for better precision-medicine treatments of cancer patients and those at risk for cancer.

6 May 2024 in Cell
Verified
Journal Article
Open access
SBShovik Bandyopadhyay
Shovik Bandyopadhyay
MDMichael P. Duffy
Michael P. Duffy
KAKyung Jin Ahn
Kyung Jin Ahn
JSJonathan H. Sussman
Jonathan H. Sussman
MPMinxing Pang
Minxing Pang
KTKai Tan
Kai Tan
Non-hematopoietic cells are essential contributors to hematopoiesis. However, heterogeneity and spatial organization of these cells in human bone marrow remain largely uncharacterized. We used single-cell RNA sequencing (scRNA-seq) to profile 29,325 non-hematopoietic cells and discovered nine transcriptionally distinct subtypes. We simultaneously profiled 53,417 hematopoietic cells and predicted their interactions with non-hematopoietic subsets. We employed co-detection by indexing (CODEX) to spatially profile over 1.2 million cells. We integrated scRNA-seq and CODEX data to link predicted cellular signaling with spatial proximity. Our analysis revealed a hyperoxygenated arterio-endosteal neighborhood for early myelopoiesis, and an adipocytic localization for early hematopoietic stem and progenitor cells (HSPCs). We used our CODEX atlas to annotate new images and uncovered mesenchymal stromal cell (MSC) expansion and spatial neighborhoods co-enriched for leukemic blasts and MSCs in acute myeloid leukemia (AML) patient samples. This spatially resolved, multiomic atlas of human bone marrow provides a reference for investigation of cellular interactions that drive hematopoiesis.

12 May 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
BHBing He
Bing He
CCChangya Chen
Changya Chen
LTLi Teng
Li Teng
KTKai Tan
Kai Tan
Enhancer mapping has been greatly facilitated by various genomic marks associated with it. However, little is available in our toolbox to link enhancers with their target promoters, hampering mechanistic understanding of enhancer–promoter (EP) interaction. We develop and characterize multiple genomic features for distinguishing true EP pairs from noninteracting pairs. We integrate these features into a probabilistic predictor for EP interactions. Multiple validation experiments demonstrate a significant improvement over state-of-the-art approaches. Systematic analyses of EP interactions across 12 cell types reveal several global features of EP interactions: (i) a larger fraction of EP interactions are cell type specific than enhancers; (ii) promoters controlled by multiple enhancers have higher tissue specificity, but the regulating enhancers are less conserved; (iii) cohesin plays a role in mediating tissue-specific EP interactions via chromatin looping in a CTCF-independent manner. Our approach presents a systematic and effective strategy to decipher the mechanisms underlying EP communication. Significance In eukaryotes, gene expression is controlled by short regulatory DNA sequences called enhancers. Understanding how an enhancer selects its target promoter(s) is a major challenge in the field of gene regulation. Advances in genomic technologies have enabled rapid and comprehensive identification of active promoters and enhancers for many cell types. However, there is a lack of methods to link bona fide enhancers and their target promoters. Here, we develop and integrate multiple genomic features into a statistical predictor for enhancer–promoter interactions. Systematic analyses of the predicted interactions across 12 cell types reveals several global features of enhancer–promoter communication. Our approach presents a systematic and effective strategy to decipher the mechanisms underlying enhancer and promoter communication.